CN Patent
CN113473980A — 在进食状态下具有改善的药代动力学的γ-羟基丁酸酯组合物
Assigned to Flamel Ireland Ltd · Expires 2021-10-01 · 5y expired
What this patent protects
提供当进食后不到两小时施用时具有改善的药代动力学性质的羟丁酸钠口服药物组合物及其治疗用途。
USPTO Abstract
提供当进食后不到两小时施用时具有改善的药代动力学性质的羟丁酸钠口服药物组合物及其治疗用途。
Drugs covered by this patent
- Cytarabine (Cytarabine) · Nippon Shinyaku Co., Ltd.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.